Kathie Jane Wachholder, MA CCC SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 100 Summit Dr, Gilberts, IL 60136 Phone: 847-697-6473 |
Karen Renaldi Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 129 Leadville Ln, Gilberts, IL 60136 Phone: 847-912-9662 |
Mrs. Julie Therese Boettcher, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 254 Evergreen Cir, Gilberts, IL 60136 Phone: 847-975-3580 |
Anthony Vittorino Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 407 Jean St, Gilberts, IL 60136 Phone: 847-204-8375 |
Village Therapy Services, Inc. Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 100 Summit Dr, Gilberts, IL 60136 Phone: 847-697-6473 |
News Archive
A team of researchers at the renowned Scripps Research Institute has discovered two new compounds that prove the existence of new binding sites on HIV protease. Associate Professor C. David Stout, senior author of the study, explained "These results open the door to a whole new approach to drug design against HIV protease," which is an enzyme used by HIV to create new, infectious viral particles.
Lung cancer is the second most common type of cancer and leading cause of cancer death in men and women, with non-small cell lung cancer (NSCLC) accounting for up to 90% of cases. Somatic mutations heavily impact the sensitivity of NSCLC patients to various drug treatments, and are critical for choosing the most effective targeted therapies for this cancer.
Research led by the Centenary Institute has discovered that immune cells accumulating within the tumor environment, called tumour-resident T cells, are a critical determinant in survival rates of patients suffering from throat cancer.
New research suggests that the presence or absence of two proteins may be important markers for long-term survival in some breast-cancer patients.
› Verified 3 days ago